Corient Private Wealth’s UiPath PATH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.55M Buy
142,072
+84,428
+146% +$1.08M ﹤0.01% 1401
2025
Q4
$894K Buy
57,644
+31,816
+123% +$495K ﹤0.01% 1941
2025
Q3
$346K Sell
25,828
-827
-3% -$9.78K ﹤0.01% 2035
2025
Q2
$341K Sell
26,655
-1,885
-7% -$22.6K ﹤0.01% 1924
2025
Q1
$294K Buy
28,540
+11,407
+67% +$147K ﹤0.01% 1866
2024
Q4
$218K Buy
17,133
+3,374
+25% +$44.6K ﹤0.01% 2072
2024
Q3
$176K Buy
13,759
+3,274
+31% +$40.1K ﹤0.01% 2245
2024
Q2
$133K Sell
10,485
-25,991
-71% -$449K ﹤0.01% 2181
2024
Q1
$827K Buy
36,476
+1,996
+6% +$46.7K ﹤0.01% 1378
2023
Q4
$856K Buy
34,480
+2,756
+9% +$53.8K ﹤0.01% 1341
2023
Q3
$543K Buy
31,724
+1,723
+6% +$28.7K ﹤0.01% 1450
2023
Q2
$496K Buy
30,001
+13,183
+78% +$211K ﹤0.01% 1455
2023
Q1
$295K Buy
16,818
+4,075
+32% +$61.6K ﹤0.01% 1616
2022
Q4
$162K Buy
+12,743
New +$157K ﹤0.01% 1519

Other funds holding PATH

Corient Private Wealth's PATH Position: Q1 2026 in Review

Corient Private Wealth increased its UiPath (PATH) stake by 146% in Q1 2026, buying an estimated $1.08M and bringing the position to 142,072 shares worth $1.55M. The position accounts for ﹤0.01% of the portfolio, ranked #1401.

Corient Private Wealth first reported a position in PATH in Q4 2022 and has held it in 14 quarters since. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

  • Corient Private Wealth held 142,072 shares of UiPath worth $1.55M as of Q1 2026.
  • Corient Private Wealth bought 84,428 UiPath shares in Q1 2026, an estimated $1.08M.
  • UiPath made up ﹤0.01% of Corient Private Wealth's portfolio in Q1 2026, its #1401 holding.
  • Corient Private Wealth first reported a position in UiPath in Q4 2022 and has held it in 14 quarters since.
  • 533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on Corient Private Wealth's 13F filing for Q1 2026, filed 15 May 2026.